GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trillium Therapeutics Inc (NAS:TRIL) » Definitions » Allowance For Loans And Lease Losses

Trillium Therapeutics (Trillium Therapeutics) Allowance For Loans And Lease Losses


View and export this data going back to 2009. Start your Free Trial

What is Trillium Therapeutics Allowance For Loans And Lease Losses?

Allowance For Loans And Lease Losses only applies to banks.


Trillium Therapeutics (Trillium Therapeutics) Business Description

Industry
Traded in Other Exchanges
N/A
Address
100 CambridgePark Drive, Suite 510, Cambridge, MA, USA, 02140
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.